· Журналы · Книги · О проекте ·Электронные версии книг издательства “Атмосфера” поступили в продажу Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru ИНТЕРНЕТ-МАГАЗИН    Лечебное дело 2023 / N 3 Саркопения и хроническая сердечная недостаточность. Часть 2 А.А. Микаелян, Ю.Р. Вараева, Ю.В. Лискова, О.А. Кисляк, Е.Г. Дмитриева, Н.М. Федотова, А.В. Стародубова Список литературы/References 1. Wang M, Hu S, Zhang F, Liu J, Mao Y. Correlation between sarcopenia and left ventricular myocardial mass in chronic heart failure patients. Aging Medicine (Milton, N.S.W.). 2020;3(2):138-141. DOI: 10.1002/agm2.12111 2. Гуляев Н.И., Адамов А.А., Ахметшин И.М. Влияние саркопении на течение и прогноз у пациентов с хронической сердечной недостаточностью. Медико-фармацевтический журнал «Пульс». 2023;25(2):124-133. [Gulyaev NI, Adamov AA, Akhmetshin IM. Influence of sarcopenia on the course and prognosis in patients with chronic heart failure. Medical & Pharmaceutical Journal “Pulse”. 2023;25(2):124-133. (In Russ.).] DOI: 10.26787/nydha-2686-6838-2023-25-2-124-133 3. Зарудский А.А. Саркопения и ее компоненты у пациентов с систолической хронической сердечной недостаточностью. Современные проблемы здравоохранения и медицинской статистики. 2020;2:132-143. [Zarudskiy AA. Sarcopenia and its components in patients with systolic heart failure. Current Problems of Health Care and Medical Statistics. 2020;2:132-143. (In Russ.).] DOI: 10.24411/2312-2935-2020-10037 4. Pipek LZ, Baptista CG, Nascimento RFV, Taba JV, Suzuki MO, do Nascimento FS, Martines DR, Nii F, Iuamoto LR, Carneiro-D’Albuquerque LA, Meyer A, Andraus W. The impact of properly diagnosed sarcopenia on postoperative outcomes after gastrointestinal surgery: a systematic review and meta-analysis. PLoS One. 2020;15(8):e0237740. DOI: 10.1371/journal.pone.0237740 5. Coletta G, Phillips SM. An elusive consensus definition of sarcopenia impedes research and clinical treatment: a narrative review. Ageing Research Reviews. 2023;86:101883. DOI: 10.1016/j.arr.2023.101883 6. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing. 2019;48(1):16-31. DOI: 10.1093/ageing/afy169 7. Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, Kojima T, Kuzuya M, Lee JSW, Lee SY, Lee WJ, Lee Y, Liang CK, Lim JY, Lim WS, Peng LN, Sugimoto K, Tanaka T, Won CW, Yamada M, Zhang T, Akishita M, Arai H. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. Journal of the American Medical Directors Association. 2020;21(3):300-307.e2. DOI: 10.1016/j.jamda.2019.12.012 8. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Abellan van Kan G, Andrieu S, Bauer J, Breuille D, Cederholm T, Chandler J, De Meynard C, Donini L, Harris T, Kannt A, Keime Guibert F, Onder G, Papanicolaou D, Rolland Y, Rooks D, Sieber C, Souhami E, Verlaan S, Zamboni M. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International Working Group on Sarcopenia. Journal of the American Medical Directors Association. 2011;12(4):249-256. DOI: 10.1016/j.jamda.2011.01.003 9. Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, Ferrucci L, Guralnik JM, Fragala MS, Kenny AM, Kiel DP, Kritchevsky SB, Shardell MD, Dam TT, Vassileva MT. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. The Journal of Gerontology. Series A. Biologic Sciences and Medical Sciences. 2014;69(5):547-558. DOI: 10.1093/gerona/glu010 10. Bhasin S, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA, Magaziner JM, Newman AB, Kiel DP, Cooper C, Guralnik JM, Cauley JA, Arai H, Clark BC, Landi F, Schaap LA, Pereira SL, Rooks D, Woo J, Woodhouse LJ, Binder E, Brown T, Shardell M, Xue QL, DʼAgostino RB Sr, Orwig D, Gorsicki G, Correa-De-Araujo R, Cawthon PM. Sarcopenia definition: the position statements of the Sarcopenia Definition and Outcomes Consortium. Journal of the American Geriatrics Society. 2020;68(7):1410-1418. DOI: 10.1111/jgs.16372 11. Alsadany MA, Sanad HT, Elbanouby MH, Ali S. Detecting a valid screening method for sarcopenia in acute care setting. Journal of Frailty, Sarcopenia and Falls. 2021;6(3):111-118. DOI: 10.22540/JFSF-06-111 12. Lee SH, Gong HS. Measurement and interpretation of handgrip strength for research on sarcopenia and osteoporosis. Journal of Bone Metabolism. 2020;27(2):85-96. DOI: 10.11005/jbm.2020.27.2.85 13. Наумов A.В., Деменок Д.В., Онучина Ю.С., Ховасова Н.О., Мороз В.И., Балаева М.М.Б. Инструментальная диагностика остеосаркопении в схемах и таблицах. Российский журнал гериатрической медицины. 2021;3:358-364. [Naumov AV, Demenok DV, Onuchina YuS, Khovasova NO, Moroz VI, Balayeva MМB. Instrumental diagnosis of osteosarcopenia in diagrams and tables. Russian Journal of Geriatric Medicine. 2021;3:358-364. (In Russ.).] DOI: 10.37586/2686-8636-3-2021-350-356 14. Фомина НВ, Уткина ЕВ. Современные методы диагностики саркопении. Сибирское медицинское обозрение. 2022;5:12-23. [Fomina NV, Utkina EV. Modern methods of sarcopenia diagnostics. Siberian Medical Review. 2022;5:12-23. (In Russ.).] DOI: 10.20333/25000136-2022-5-12-23 15. Драпкина О.М., Максимова О.А., Шептулина А.Ф., Джиоева О.Н. Биоимпедансный анализ состава тела: что важно знать терапевту? Профилактическая медицина. 2022;25(10):91‑96. [Drapkina OM, Maksimova OA, Sheptulina AF, Dzhioeva ON. Bioimpedance analysis of body composition: what should general practitioner know? Profilakticheskaya Meditsina. 2022;25(10):91‑96. (In Russ.).] DOI: 10.17116/profmed20222510191 16. Becroft L, Ooi G, Forsyth A, King S, Tierney A. Validity of multi-frequency bioelectric impedance methods to measure body composition in obese patients: a systematic review. International Journal of Obesity (2005). 2019;43(8):1497-1507. DOI: 10.1038/s41366-018-0285-9 17. Shankaran M, Czerwieniec G, Fessler C, Wong PA, Killion S, Turner SM, Hellerstein MK, Evans WJ. Dilution of oral D(3)-creatine to measure creatine pool size and estimate skeletal muscle mass: development of a correction algorithm. Journal of Cachexia, Sarcopenia and Muscle. 2018;9(3):540-546. DOI: 10.1002/jcsm.12278 18. Clark RV, Walker AC, O’Connor-Semmes RL, Leonard MS, Miller RR, Stimpson SA, Turner SM, Ravussin E, Cefalu WT, Hellerstein MK, Evans WJ. Total body skeletal muscle mass: estimation by creatine (methyl-d3) dilution in humans. Journal of Applied Physiology (Bethesda, Md.: 1985). 2014;116(12):1605-1613. DOI: 10.1152/japplphysiol.00045.2014 19. Cawthon PM, Orwoll ES, Peters KE, Ensrud KE, Cauley JA, Kado DM, Stefanick ML, Shikany JM, Strotmeyer ES, Glynn NW, Caserotti P, Shankaran M, Hellerstein M, Cummings SR, Evans WJ; Osteoporotic Fractures in Men (MrOS) Study Research Group. Strong relation between muscle mass determined by D3-creatine dilution, physical performance, and incidence of falls and mobility limitations in a prospective cohort of older men. The Journal of Gerontology: Series A. Biological Sciences and Medical Sciences. 2019;74(6):844-852. DOI: 10.1093/gerona/gly129 20. Cawthon PM, Peters KE, Cummings SR, Orwoll ES, Hoffman AR, Ensrud KE, Cauley JA, Evans WJ; Osteoporotic Fractures in Men (MrOS) Study Research Group. Association between muscle mass determined by D3-creatine dilution and incident fractures in a prospective cohort study of older men. Journal of Bone and Mineral Research. 2022;37(7):1213-1220. DOI: 10.1002/jbmr.4505 21. McCarthy C, Schoeller D, Brown JC, Gonzalez MC, Varanoske AN, Cataldi D, Shepherd J, Heymsfield SB. D3-creatine dilution for skeletal muscle mass measurement: historical development and current status. Journal of Cachexia, Sarcopenia and Muscle. 2022;13(6):2595-2607. DOI: 10.1002/jcsm.13083 22. Guttikonda D, Smith AL. Sarcopenia assessment techniques. Clinical Liver Disease. 2021;18(4):189-192. DOI: 10.1002/cld.1111 23. Мокрышева Н.Г., Крупинова Ю.А., Володичева В.Л., Мирная С.С., Мельниченко Г.А. Саркопения глазами эндокринолога. Остеопороз и остеопатии. 2019;22(4):19-26. [Mokrysheva NG, Krupinova YuA, Volodicheva VL, Mirnaya SS, Melnichenko GA. A view at sarcopenia by endocrinologist. Osteoporosis and Bone Diseases. 2019;22(4):19-26. (In Russ.).] DOI: 10.14341/osteo12465 24. Dommershuijsen LJ, Isik BM, Darweesh SKL, van der Geest JN, Ikram MK, Ikram MA. Unraveling the association between gait and mortality – one step at a time. The Journals of Gerontology. Series A. Biological Sciences and Medical Sciences. 2020;75(6):1184-1190. DOI: 10.1093/gerona/glz282 25. Grundtvig M, Eriksen-Volnes T, Ørn S, Slind EK, Gullestad L. 6 min walk test is a strong independent predictor of death in outpatients with heart failure. ESC Heart Failure. 2020;7(5):2904-2911. DOI: 10.1002/ehf2.12900 26. Lena A, Hadzibegovic S, von Haehling S, Springer J, Coats AJ, Anker MS. Sarcopenia and cachexia in chronic diseases: from mechanisms to treatment. Polish Archives of Internal Medicine. 2021;131(12):16135. DOI: 10.20452/pamw.16135 27. Gingrich A, Volkert D, Kiesswetter E, Thomanek M, Bach S, Sieber CC, Zopf Y. Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients. BMC Geriatrics. 2019;19(1):120. DOI: 10.1186/s12877-019-1115-1 28. McDonald MN, Wouters EFM, Rutten E, Casaburi R, Rennard SI, Lomas DA, Bamman M, Celli B, Agusti A, Tal-Singer R, Hersh CP, Dransfield M, Silverman EK. It’s more than low BMI: prevalence of cachexia and associated mortality in COPD. Respiratory Research. 2019;20(1):100. DOI: 10.1186/s12931-019-1073-3 29. Emami A, Saitoh M, Valentova M, Sandek A, Evertz R, Ebner N, Loncar G, Springer J, Doehner W, Lainscak M, Hasenfuß G, Anker SD, von Haehling S. Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). European Journal of Heart Failure. 2018;20(11):1580-1587. DOI: 10.1002/ejhf.1304 30. Carbone S, Billingsley HE, Rodriguez-Miguelez P, Kirkman DL, Garten R, Franco RL, Lee DC, Lavie CJ. Lean mass abnormalities in heart failure: the role of sarcopenia, sarcopenic obesity, and cachexia. Current Problems in Cardiology. 2020;45(11):100417. DOI: 10.1016/j.cpcardiol.2019.03.006 31. Российское кардиологическое общество (РКО); Национальное общество специалистов по заболеваниям миокарда и сердечной недостаточности (НОИСН); Общество специалистов по сердечной недостаточности (ОССН). Хроническая сердечная недостаточность. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(11):4083. [Russian Society of Cardiology; National Society of Myocardial Diseases and Heart Failure; Society of Heart Failure Specialists. Clinical practice guidelines for chronic heart failure 2020. Russian Journal of Cardiology. 2020;25(11):4083. (In Russ.).] DOI: 10.15829/1560-4071-2020-4083 32. Купряшов А.А., Ривняк М.И., Колоскова Н.Н., Глушко Л.А., Мироненко В.А., Бокерия Л.А. Факторы, определяющие физическую работоспособность больных с недостаточностью кровообращения и анемией. Креативная кардиология. 2019;13(4):349-362. [Kupryashov AA, Rivnyak MI, Koloskova NN, Glushko LA, Mironenko VA, Bockeria LA. Factors determining the physical performance of patients with heart failure and anemia. Creative Cardiology. 2019;13(4):349-362. (In Russ.).] DOI: 10.24022/1997-3187-2019-13-4-349-362 33. Curcio F, Testa G, Liguori I, Papillo M, Flocco V, Panicara V, Galizia G, Della-Morte D, Gargiulo G, Cacciatore F, Bonaduce D, Landi F, Abete P. Sarcopenia and heart failure. Nutrients. 2020;12(1):211. DOI: 10.3390/nu12010211 34. Григорьева И.И., Раскина Т.А., Летаева М.В., Малышенко О.С., Аверкиева Ю.В., Масенко В.Л., Коков А.Н. Саркопения: особенности патогенеза и диагностики. Фундаментальная и клиническая медицина. 2019;4(4):105-116. [Grigoryeva II, Raskina TA, Letayeva MV, Malyshenko OS, Averkiyeva YuV, Masenko VL, Kokov AN. Sarcopenia: pathogenesis and diagnosis. Fundamental and Clinical Medicine. 2019;4(4):105-116. (In Russ.).] DOI: 10.23946/2500-0764-2019-4-4-105-116 35. Huot JR, Pin F, Narasimhan A, Novinger LJ, Keith AS, Zimmers TA, Willis MS, Bonetto A. ACVR2B antagonism as a countermeasure to multi-organ perturbations in metastatic colorectal cancer cachexia. Journal of Cachexia, Sarcopenia and Muscle. 2020;11(6):1779-1798. DOI: 10.1002/jcsm.12642 36. Brent MB, Brüel A, Thomsen JS. PTH (1-34) and growth hormone in prevention of disuse osteopenia and sarcopenia in rats. Bone. 2018;110:244-253. DOI: 10.1016/j.bone.2018.02.017 37. Correa C, Bieger P, Perry IS, Souza GC. Testosterone supplementation on sarcopenia components in chronic patients: a systematic review and meta-analysis. Current Pharmaceutical Design 2022;28(7):586-594. DOI: 10.2174/1381612827666211115155541 38. Всемирная организация здравоохранения. Информационные бюллетени. Физическая активность. Опубликовано 5 октября 2022. Ссылка активна на 16.10.2023. [World Health Organization. Fact sheets. Physical activity. Published 2022 Oct 05. (In Russ.).] https://www.who.int/ru/news-room/fact-sheets/detail/physical-activity 39. Alizadeh Pahlavani H. Exercise therapy for people with sarcopenic obesity: myokines and adipokines as effective actors. Frontiers in Endocrinology. 2022;13:811751. DOI: 10.3389/fendo.2022.811751 40. Moro T, Brightwell CR, Volpi E, Rasmussen BB, Fry CS. Resistance exercise training promotes fiber type-specific myonuclear adaptations in older adults. Journal of Applied Physiology. (Bethesda, Md.: 1985);2020;128(4):795-804. DOI: 10.1152/japplphysiol.00723.2019 41. Hurst C, Robinson SM, Witham MD, Dodds RM, Granic A, Buckland C, De Biase S, Finnegan S, Rochester L, Skelton DA, Sayer AA. Resistance exercise as a treatment for sarcopenia: prescription and delivery. Age and Aging. 2022;51(2):afac003. DOI: 10.1093/ageing/afac003 42. Peterson MD, Sen A, Gordon PM. Influence of resistance exercise on lean body mass in aging adults: a meta-analysis. Medicine & Science in Sports & Exercise. 2011;43(2):249-258. DOI: 10.1249/MSS.0b013e3181eb6265 43. Vikberg S, Sörlén N, Brandén L, Johansson J, Nordström A, Hult A, Nordström P. Effects of resistance training on functional strength and muscle mass in 70-year-old individuals with pre-sarcopenia: a randomized controlled trial. Journal of the American Medical Directors Association. 2019;20(1):28-34. DOI: 10.1016/j.jamda.2018.09.011 44. Lin Y, Fan R, Hao Z, Li J, Yang X, Zhang Y, Xia Y. The association between physical activity and insulin level under different levels of lipid indices and serum uric acid. Frontiers in Physiology. 2022;13:809669. DOI: 10.3389/fphys.2022.809669 45. Alizadeh Pahlavani H, Laher I, Knechtle B, Zouhal H. Exercise and mitochondrial mechanisms in patients with sarcopenia. Frontiers in Physiology. 2022;13:1040381. DOI: 10.3389/fphys.2022.1040381 46. Recchia F, Leung CK, Yu AP, Leung W, Yu DJ, Fong DY, Montero D, Lee CH, Wong SHS, Siu PM. Dose-response effects of exercise and caloric restriction on visceral adiposity in overweight and obese adults: a systematic review and meta-analysis of randomised controlled trials. British Journal of Sports Medicine. 2023;57(16):1035-1041. DOI: 10.1136/bjsports-2022-106304 47. Lorenz DS, Bailey L, Wilk KE, Mangine RE, Head P, Grindstaff TL, Morrison S. Blood flow restriction training. Journal of Athletic Training. 2021;56(9):937-944. DOI: 10.4085/418-20 48. Kim DY, Oh SL, Lim JY. Applications of eccentric exercise to improve muscle and mobility function in older adults. Annals of Geriatric Medicine and Research. 2022;26(1):4-15. DOI: 10.4235/agmr.21.0138 49. Hsu KJ, Liao CD, Tsai MW, Chen CN. Effects of exercise and nutritional intervention on body composition, metabolic health, and physical performance in adults with sarcopenic obesity: a meta-analysis. Nutrients. 2019;11(9):2163. DOI: 10.3390/nu11092163 50. Lu L, Mao L, Feng Y, Ainsworth BE, Liu Y, Chen N. Effects of different exercise training modes on muscle strength and physical performance in older people with sarcopenia: a systematic review and meta-analysis. BMC Geriatrics. 2021;21(1):708. DOI: 10.1186/s12877-021-02642-8 51. Wu S, Ning HT, Xiao SM, Hu MY, Wu XY, Deng HW, Feng H. Effects of vibration therapy on muscle mass, muscle strength and physical function in older adults with sarcopenia: a systematic review and meta-analysis. European Review of Aging and Physical Activity. 2020;17:14. DOI: 10.1186/s11556-020-00247-5 52. Teschler M, Heimer M, Schmitz B, Kemmler W, Mooren FC. Four weeks of electromyostimulation improves muscle function and strength in sarcopenic patients: a three-arm parallel randomized trial. Journal of Cachexia, Sarcopenia and Muscle. 2021;12(4):843-854. DOI: 10.1002/jcsm.12717 53. Teschler M, Mooren FC. (Whole-body) electromyostimulation, muscle damage, and immune system: a mini review. Frontiers in Physiology. 2019;10:1461. DOI: 10.3389/fphys.2019.01461 54. Volkert D, Beck AM, Cederholm T, Cruz-Jentoft A, Hooper L, Kiesswetter E, Maggio M, Raynaud-Simon A, Sieber C, Sobotka L, van Asselt D, Wirth R, Bischoff SC. ESPEN practical guideline: clinical nutrition and hydration in geriatrics. Clinical Nutrition (Edinburgh, Scotland). 2022;41(4):958-989. DOI: 10.1016/j.clnu.2022.01.024 55. Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, Phillips S, Sieber C, Stehle P, Teta D, Visvanathan R, Volpi E, Boirie Y. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. Journal of the American Medical Directors Association. 2013;14(8):542-559. DOI: 10.1016/j.jamda.2013.05.021 56. Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero JJ, Chan W, Fouque D, Friedman AN, Ghaddar S, Goldstein-Fuchs DJ, Kaysen GA, Kopple JD, Teta D, Yee-Moon Wang A, Cuppari L. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. American Journal of Kidney Diseases. 2020;76(3Suppl 1):S1-S107. DOI: 10.1053/j.ajkd.2020.05.006 57. Kaur D, Rasane P, Singh J, Kaur S, Kumar V, Mahato DK, Dey A, Dhawan K, Kumar S. Nutritional interventions for elderly and considerations for the development of geriatric foods. Current Aging Science. 2019;12(1):15-27. DOI: 10.2174/1874609812666190521110548 58. Deutz NE, Matheson EM, Matarese LE, Luo M, Baggs GE, Nelson JL, Hegazi RA, Tappenden KA, Ziegler TR; NOURISH Study Group. Readmission and mortality in malnourished, older, hospitalized adults treated with a specialized oral nutritional supplement: a randomized clinical trial. Clinical Nutrition (Edinburgh, Scotland). 2016;35(1):18-26. DOI: 10.1016/j.clnu.2015.12.010 59. Remelli F, Vitali A, Zurlo A, Volpato S. Vitamin D deficiency and sarcopenia in older persons. Nutrients. 2019;11(12):2861. DOI: 10.3390/nu11122861 60. Cheng SH, Chen KH, Chen C, Chu WC, Kang YN. The optimal strategy of vitamin D for sarcopenia: a network meta-analysis of randomized controlled trials. Nutrients. 2021;13(10):3589. DOI: 10.3390/nu13103589    [ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]